瘦吧科技创始人黄祥泓在会上发表重要致辞，结合行业痛点与企业近9年服务436万用户的实践成果，以 详实数据与前瞻性战略规划，展现出对行业发展趋势的深刻洞察与推动国民健康事业发展的坚定决心： 用科技重塑健康，让预防成为普惠每个人的生活方式。 (瘦吧科技创始人黄祥泓上台致辞) 响应国家战略，瘦吧科技顺势崛起 随着"健康中国2030"战略的深入推进，国民健康体重管理已成为慢性病防控的核心议题。面对超半数成 年人面临超重或肥胖的严峻现实，传统人工干预模式暴露出效率低、覆盖窄的短板，科技赋能迫在眉 睫。2016年，瘦吧科技应势而生，坚定不移践行"让更多人因我们而健康"的使命，依托AI与大数据的创 新应用，与国家战略同频共振，成为健康中国建设的先行者。 5月11日，由瘦吧科技主办、新华网（603888）联合发起，央广网、人民网特别支持的"健康体重·因AI 新生"国民健康体重管理计划发展大会暨"百亿健康补贴·一起来瘦吧"行动发布会在北京国际会议中心隆 重举行。大会聚焦AI技术与大健康产业的深度融合，发布多项重量级战略举措，旨在以科技之力推动 全民健康体重管理科学化、普惠化发展。 5·11行动发布，科技普惠与公益升级 在5月1 ...

今天分享的是：2024中国消费健康行业发展报告 报告共计：154页 《2024中国消费健康行业发展报告》由商务部投资促进事务局等联合发布，全面剖析中国消费健康行业的现状、趋势、挑战机遇及未来发展方向。在发展现 状方面，政策与市场双向推动行业发展，中国生命健康产业和消费健康市场规模持续增长，涵盖OTC、保健品、个人护理和医学营养品的四位一体健康管理 体系不断完善，产品创新满足个性化需求，监管也持续完善。未来，政策环境将不断优化，推动产业升级、简化审批流程、加强质量监管；消费需求呈全龄 化和下沉趋势，对产品和配套服务要求提升；渠道、服务和技术持续创新，供应链优化，电商平台发展，产品剂型创新且更个性化，远程医疗等技术助力行 业下沉；ESG理念逐步增强，企业向"防 - 治 - 养"一体化转型。行业面临诸多挑战与机遇，虽市场潜力巨大，但存在市场准入和注册无单独路径、临床可及 性潜力待挖掘、物流限制供应链升级等问题。对此，报告建议企业创新营销和商业模式，利用社交媒体精准营销，构建订阅制等新商业模式；行业共建生态 圈，企业间加强联合研发创新，监管机构与企业协同，企业关注消费者需求创新。此外，报告还介绍了行业四大细分门类的发 ...

证券代码： 002900 证券简称：哈三联 哈尔滨三联药业股份有限公司 投资者关系活动记录表 编号：2025-001 | 投资者关系活 | □特定对象调研 □ 分析师会议 | | □ 现场参观 | | --- | --- | --- | --- | | 动类别 | □ 媒体采访 | √ 业绩说明会 | □ 其他 | | | □ 新闻发布会 | □ 路演活动 | | | 参与单位名称 | 关于参加黑龙江辖区上市公司 年投资者网上集体接待日活动暨业 | 2025 | | | 及人员姓名 | 绩说明会，投资者网上提问。 | | | | 时间 | 2025 年 5 月 14 日（周三）下午 14:00~16:30 | | | | 地点 | 全景网"投资者关系互动平台"（https://ir.p5w.net） | | | | 公司接待人员 | 1、董事、副总裁兼董事会秘书梁延飞先生 | | | | 姓名 | 2、财务总监赵志成先生 | | | | | 1、公司医美产业发展如何？有没有特色优势产品？ | | | | | 尊敬的投资者您好：公司大健康板块目前包括化妆品、医用敷料、 | | | | | "好好"系列纳米乳化饮 ...

Core Viewpoint - The conference "Healthy Weight: Reborn through AI" organized by Shouba Technology aims to transition weight management from an experience-driven approach to a data-driven one, contributing to the construction of a healthy China [1][3][19] Group 1: Conference Overview - The event was held on World Obesity Day, attracting nearly 2,000 participants including doctors, nutritionists, and health managers from various regions [1][3] - The conference emphasized the importance of policy guidance, technological innovation, and public welfare in addressing obesity as a significant public health issue [3][19] Group 2: Company Initiatives - Shouba Technology has developed an AI weight management model based on over 1 billion health data points from millions of users, offering services like AI body fat assistants and nutritionists [4] - The company has served over 1.3 million users, helping them lose a total of over 5.45 million kilograms [4] - Shouba Technology announced a "100 Billion Health Subsidy Plan" to promote scientific weight loss and support community health initiatives [7][8] Group 3: Policy and Collaboration - The National Health Commission highlighted the need for multi-sector collaboration to tackle obesity, shifting the focus from treatment to prevention [7][10] - Shouba Technology has formed partnerships with various institutions, including the Chinese Academy of Food Fermentation Industry and Peking University, to enhance health management and research [10][13] Group 4: Public Welfare Initiatives - The "Meat Transfer" public welfare plan was launched, where funds are donated to improve nutrition for rural children based on users' weight loss achievements [4][14] - The initiative aims to create a sustainable cycle of health behavior transformation into social benefits [14] Group 5: Scientific Consensus and Future Directions - Experts from various fields agreed on the necessity of a multi-faceted approach to effective weight management, integrating technology, policy, and psychological support [15][18] - The conference outlined a clear path for national health weight management, emphasizing the role of AI in driving health equity and innovation [19]

为增强社区居民健康意识、提升自我保健能力，近日，"AI+新国医技术免费健康培训及慢病风险筛 查"活动在仲景街道东关社区拉开了序幕，东关社区携手仲景二社区卫生服务中心，为辖区居民开展主 题培训和基于视网膜影像的人工智能健康检查即鹰瞳AI眼底检查，向居民普及健康常识，助力居民提 早发现并干预心梗、脑梗等常见重症风险。 社区负责人表示，为践行健康中国战略，提升居民慢性病防治意识，实现心梗、脑梗等心脑血管疾病 的"早筛、早诊、早干预"，今后将继续开展此类活动，不断创新活动形式和内容，让更多的居民受益， 为构建健康社区贡献力量。 相信随着人工智能技术的不断发展，基层医疗服务将更加智能化、精准化，基层社区卫生服务中心将更 好地为居民健康保驾护航，让"健康中国"战略具象化为百姓触手可及的获得感。鹰瞳科技将始终秉 持"让健康无处不在"的理念，运用先进AI技术让优质医疗资源触手可及，为加速实现健康中国2030的宏 伟蓝图贡献AI力量。 注：图文内容采编自河南广播电视台大象新闻，有修改 活动伊始，东关社区邀请了医疗专家为居民们带来了一场场精彩纷呈的健康知识讲座。专家们围绕常见 疾病的预防、合理膳食搭配、科学运动方法等主题，用通俗 ...

中国发展网讯 闫颖琳、记者皮泽红报道 2025年5月13日上午，由广州市卫生健康委和黄埔区卫生健康局 联合主办的大肠癌基因筛查项目暨肠道健康宣传月主题宣传活动在文冲·幸福里成功举办。广州市卫生 健康委员会副主任、广州市疾病预防控制局专职局长张屹，黄埔区、花都区、增城区卫生健康局有关领 导，中山大学附属第六医院结直肠外科教授、前海人寿广州总医院名誉院长汪建平等出席现场活动。 大肠癌防控最核心的工作内容就是为全市大肠癌高危人群开展早期筛查，筛查工作主要分初筛及精筛， 为使得群众在家门口就能参与筛查，广州市搭建了以与群众关系最为密切的社区卫生服务中心/乡镇卫 生院为网底，主要负责大肠癌风险评估和粪便隐血检测，此为项目初步筛查，对初筛阳性患者进行转 介；各区选择具备较强肠镜检查水平的医院作为定点医疗机构，主要负责精筛，即为社区发现的阳性者 开展肠镜检查，以及提供后续的治疗服务；依托疾病控制机构建立了市区两级的项目管理团队，负责项 目的管理、组织培训、督导等；临床技术支撑机构负责规范定点医疗机构的检查质量，通过多路径保证 工作落实到位。项目开展10年来，全市共完成81.71万人次初筛，发现高风险人群12.91万人，早诊 ...

Group 1 - The "She Health - Meituan Women's Health Public Welfare Program" was officially launched in Shanghai, focusing on creating a health management system for over 30 working women through a collaboration between government, enterprises, and medical institutions [1][3] - Beijing Tongrentang, a representative brand of traditional Chinese medicine, emphasizes the importance of liver health for women and integrates the concept of "preventive treatment" into health management, addressing modern women's health needs [3][5] - The program aims to enhance health awareness from individual to societal levels, promoting the core idea of "soothing the liver and relieving stress" [3][5] Group 2 - The collaboration with Meituan to release the "Women's Health White Paper" is a significant initiative in response to the "Healthy China" strategy, aiming to provide more precise health services through data insights and resource integration [5] - The event featured a health consultation area where experienced traditional Chinese medicine practitioners offered personalized health solutions for issues like "liver stagnation and qi deficiency" [7] - Beijing Tongrentang's mission is to make traditional Chinese medicine accessible to everyone, ensuring that every working woman can thrive with a balanced approach to health [7]

本报讯 （记者 解 磊）为推动科研成果向公众健康价值转化，在近日举办的"生命早期营养与健康：科 技创新与产业发展论坛"上，国家乳业技术创新中心（以下简称"乳业国创中心"）携手中国食品科学技 术学会正式启动了"中国食品科学技术学会食品科技专项基金——国家乳业技术创新中心科普基金"，旨 在普及乳品科学知识、引导理性消费、推动行业创新，通过多元化科普内容与创新传播形式，提升公众 对乳品营养价值的认知，化解消费误区，拓展乳品消费场景，助力健康中国建设。 科普是连接科研与消费端的桥梁，据介绍，该基金将围绕五个核心方向开展科普工作：科学解读乳品常 见认知误区、谣言，倡导科学认识乳品；多方位解读乳品健康价值，引导科学消费乳品；基于科学证 据，打造乳品消费新场景；追溯我国乳品起源，传承乳品历史与文化；开展乳品认知洞察及策略研究， 为有效开展乳品科普工作提供专业技术指引。 此外，四川大学曾果教授提出膳食结构优化促进儿童健康策略；江南大学周鹏教授阐述了婴幼儿配方奶 粉中蛋白组成对蛋白质和矿物质吸收特性的影响；中国农业大学李依璇副教授则详解乳铁蛋白与原生 DHA的儿童成长功能性优势。 乳业国创中心成员单位东北农业大学食品学院教授、 ...

Core Viewpoint - The article highlights the launch of the online public welfare live broadcast program "Zhi Mian Da Ming Yi" by Taikang Pension in 2024, aimed at promoting correct health knowledge and improving public health literacy in response to the Chinese government's health priorities [1]. Group 1: Program Overview - "Zhi Mian Da Ming Yi" covers various health topics such as respiratory disease prevention, cardiovascular health, gynecological tumors, seasonal allergy protection, weight management, and gut health [1]. - The program features experts from top medical institutions, including Peking Union Medical College Hospital and Beijing Anzhen Hospital, who provide accessible explanations of health knowledge [1]. - The program has conducted 12 health science live broadcasts, attracting over 260,000 viewers through the Taikang Health Life video account [1]. Group 2: Health Management Services - Taikang Pension offers a range of customized health management services for employees and their families, including online consultations, medication services, hospitalization assistance, and health lectures [5]. - The services aim to cover all aspects of health maintenance and disease treatment, aligning with the concept of comprehensive health management throughout the life cycle [6]. Group 3: Future Plans - In 2025, the program plans to strengthen collaboration with provincial health commissions and medical associations, conducting both online and offline health activities [7]. - The initiative aims to foster a "health culture" within companies and provide tangible health benefits to employees, continuing to focus on customer-centric health management services [7].

Core Insights - Wanze Co., Ltd. has been recognized for its outstanding performance in the fields of micro-ecological medicine and high-temperature alloys, winning two significant awards at the 2025 China Listed Company Brand Value List Conference [1] - The company's dual business strategy of "medical + high-end manufacturing" has proven successful, showcasing its ability to innovate and develop across high-barrier industries [1][4] Company Development - Wanze Co., Ltd. has evolved from a single business focus in real estate at its inception in 1992 to a dual-driven model, fully divesting from real estate in 2019 to concentrate on its core areas [1] - The company has made strategic decisions aligned with national policies, particularly in the context of domestic substitution and the Healthy China initiative [4] Financial Performance - In 2024, Wanze's subsidiary, Wanze Shuangqi Pharmaceutical, achieved revenues of 794 million yuan, a year-on-year increase of 13.43%, with net profits reaching 330 million yuan, up 39.8% [4] - The company has significantly increased its R&D investment, reaching 209 million yuan in 2024, a growth of 27.48%, and has accumulated 228 patents [5] Market Opportunities - The domestic aviation engine market is rapidly growing, with less than 30% self-sufficiency in high-end materials, positioning Wanze to capitalize on domestic substitution opportunities [7] - The global micro-ecological drug market exceeds one trillion dollars, with core products like "Jin Shuangqi" and "Ding Junsheng" expanding into new indications to unlock further growth [7] Strategic Initiatives - Wanze Co., Ltd. is actively integrating resources in the aviation engine and micro-ecological sectors through acquisition funds, enhancing technical collaboration and market influence [7] - The company aims to transition from a traditional micro-ecological product supplier to a comprehensive "microbial medical solution provider" through a forward-looking "three-dimensional innovation strategy" [7]